<DOC>
	<DOC>NCT01687426</DOC>
	<brief_summary>The purpose of this study is to determine the intraocular Pressure (IOP) lowering response and evaluate the safety of brimonidine tartrate 0.025% ophthalmic solution in adult subjects with open angle glaucoma or ocular hypertension.</brief_summary>
	<brief_title>Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Be at least 18 years of age at Visit 1 (Screening), of either sex and any race Be willing and able to provide written informed consent prior to any study procedures being performed. Be willing and able to follow all instructions and attend all study visits. Be willing to discontinue use of disallowed medication Have a documented diagnosis of ocular hypertension, open angle glaucoma or chronic angle closure glaucoma with a patent iridotomy. Have known sensitivity or poor tolerance to brimonidine or any other component of the study medications. Have any form of glaucoma other than openangle glaucoma, ocular hypertension or chronic angle closure glaucoma with patent iridotomy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>